May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Diego A. Díaz García: Perioperative therapy is reshaping early-stage oncogene-driven NSCLC
May 14, 2025, 09:05

Diego A. Díaz García: Perioperative therapy is reshaping early-stage oncogene-driven NSCLC

Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X about recent paper Teja Voruganti and colleagues authored:

“Perioperative therapy is reshaping early-stage oncogene-driven NSCLC.
EGFR+ disease has adjuvant osimertinib – but what about ALK, BRAF, KRAS?
Should TKIs replace or complement chemo-IO?
Molecular testing, MRD, and smarter sequencing are key. More answers coming soon.”
Perioperative therapy

Title: Perioperative Therapy in Oncogene-Driven Non–Small Cell Lung Cancer: Current Strategies and Unanswered Questions

Journal: American Society of Clinical Oncology Educational Book

Authors: Teja Voruganti, Rosalyn Marar, Benjamin Bleiberg, Edoardo Garbo, Biagio Ricciuti, Kaushal Parikh, and Charu Aggarwal

Read Full Article.

Diego A. Díaz García: Perioperative therapy is reshaping early-stage oncogene-driven NSCLC

More posts featuring NSCLC on OncoDaily.